Arrhythmia Cohort Study
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Normal treatment with catheter ablation or medicine, Drug Treatment.
- Who it may be relevant to
- Registry conditions: Arrhythmia. Basic parameters: 18 years — 90 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- China
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
The goal of this prospective, observational registry study is to evaluate the long-term effectiveness, safety, and impact of different kinds of treatment on the quality of life across diverse arrhythmia subtypes and patient populations in hospitalized adults with cardiac arrhythmias (including atrial fibrillation, atrial flutter, supraventricular tachycardia, and ventricular arrhythmias) undergoing routine clinical care.
Interventions
- Device Normal treatment with catheter ablation or medicine
Routine clinical care with catheter ablation and/or medicine; real-world clinical cases - Drug Drug Treatment
Routine clinical care with medicine; real-world clinical cases
Primary outcome measures
- Arrhythmia recurrence [Time frame: 1 year]
- All-cause death [Time frame: 1 year]
Secondary outcome measures (8)
- Arrhythmia recurrence [Time frame: 5 year]
- All-cause death [Time frame: 5 year]
- Cardiovascular death [Time frame: 1 year]
- Cardiovascular death [Time frame: 5 year]
- Heart failure [Time frame: 1 year]
- Heart failure [Time frame: 5 year]
- Cardiovascular hospitalization [Time frame: 1 year]
- Cardiovascular hospitalization [Time frame: 5 year]
Eligibility criteria
Inclusion criteria
- Patients hospitalized for any type of arrhythmia
Exclusion criteria
- Patients currently participating in interventional clinical trials that may confound data collection or outcome assessment in this study.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Study design
- Observational model
- Cohort
Study locations
China · 1 center
- Deyong Long — Beijing
Identifiers
NCT: NCT07123896 · KS2025136